LQDA 9.91 (+1.33%)
US53635D2027BiotechnologyBiotechnology

Liquidia (LQDA) Stock Highlights

9.91 | +1.33%
2024-09-19 03:44:03
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension.

Statistics

Range Today
9.68 10.1
Volume Today 1.14M
Range 1 Year
5.71 16.99
Volume 1 Year 238.87M
Range 3 Year
2.52 16.99
Volume 3 Year 645.33M
Range 10 Year
2.25 38.46
Volume 10 Year 936.42M

Highlights

Market Capitalization 826.48M (small)
Floating Shares 46.82M
Current Price 9.91
Price To Earnings -6.2
Price To Revenue 47.71
Price To Book 11.93
Earnings Per Share -1.58
Payout Ratio 0%

Performance

Latest +1.33%
1 Month +10.73%
3 Months -25.49%
6 Months -37.16%
1 Year +53.17%
3 Years +278.24%
5 Years +147.75%
10 Years -19.1%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.